The Rationale of Inositol Therapy in Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS)'s rate is about 6% to10% among the reproductive aged women; it is characterized by menstrual cycle irregularity with oligoanovulation, hyperandrogenism, insulin resistance, and compensatory hyperinsulinemia
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
Laganà, As
Primo
;Chiofalo, B;Vitale, Sg.Ultimo
2017-01-01
Abstract
The Rationale of Inositol Therapy in Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS)'s rate is about 6% to10% among the reproductive aged women; it is characterized by menstrual cycle irregularity with oligoanovulation, hyperandrogenism, insulin resistance, and compensatory hyperinsulinemiaFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome.pdf
accesso aperto
Descrizione: Full text articolo pubblicato su rivista
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
82.01 kB
Formato
Adobe PDF
|
82.01 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
